We are live on ! Find out more
GHDX

Genomic Health, Inc.
GHDX

Delisted

GHDX was delisted on the 7th of November, 2019.

Back to rankings

134 hedge funds and large institutions have $1.01B invested in Genomic Health, Inc. in 2017 Q3 according to their latest regulatory filings, with 19 funds opening new positions, 58 increasing their positions, 29 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

171% more first-time investments, than exits

New positions opened: 19 | Existing positions closed: 7

100% more repeat investments, than reductions

Existing positions increased: 58 | Existing positions reduced: 29

8% more funds holding

Funds holding: 124 → 134 (+10)

0% more capital invested

Capital invested by funds: $1.01B → $1.01B (+$809K)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

Holders
134
Holders Change
+10
Holders Change %
+8.06%
% of All Funds
3.34%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
19
Increased
58
Reduced
29
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
+$13.3M
2
Loomis, Sayles & Company
Loomis, Sayles & Company
Massachusetts
+$2.67M
3
NI
Numeric Investors
Massachusetts
+$2.62M
4
Morgan Stanley
Morgan Stanley
New York
+$2.57M
5
Goldman Sachs
Goldman Sachs
New York
+$2.49M

Top Sellers

Rank Fund Capital Flow
1
CWAM
Columbia Wanger Asset Management
Illinois
-$8.86M
2
BlackRock
BlackRock
New York
-$7.91M
3
Lord, Abbett & Co
Lord, Abbett & Co
New Jersey
-$4.6M
4
SCA
Secor Capital Advisors
New York
-$1.51M
5
Two Sigma Investments
Two Sigma Investments
New York
-$1.24M
Name Holding Trade Value Shares
Change 		Change in
Stake
PHK
126
Point72 Hong Kong
Hong Kong
$11K +$11.3K +357 New
TCOV
127
Trust Company of Vermont
Vermont
$9K – – –
CHP
128
Cable Hill Partners
Oregon
$7K -$95 -3 -1%
FQ
129
First Quadrant
California
$7K +$6.56K +208 New
PMFA
130
Plante Moran Financial Advisors
Michigan
$6K – – –
SEI Investments
131
SEI Investments
Pennsylvania
$4K +$3.56K +113 New
JCM
132
Jacobi Capital Management
Pennsylvania
$3K – – –
ST
133
Smithfield Trust
Pennsylvania
$3K – – –
IA
134
IFP Advisors
Florida
$3K +$2.21K +70 +778%
Lord, Abbett & Co
135
Lord, Abbett & Co
New Jersey
– -$4.6M -141,392 Closed
SCA
136
Secor Capital Advisors
New York
– -$1.51M -46,551 Closed
TC
137
TFS Capital
Pennsylvania
– -$905K -27,798 Closed
ARTA
138
A.R.T. Advisors
New York
– -$275K -8,478 Closed
AIM
139
Acrospire Investment Management
Illinois
– -$57K -1,744 Closed
Creative Planning
140
Creative Planning
Kansas
– -$3K -100 Closed
HH
141
HWG Holdings
Texas
– -$2K -49 Closed
2 3 4 5
6

GHDX Hedge Fund Activity: Q3 2017 in Review

134 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Genomic Health, Inc. (GHDX) for Q3 2017, worth a combined $1.01B — up 0.08% from $1.01B a quarter earlier.

Buyers outnumbered sellers: 19 funds opened new GHDX positions and 7 closed out — a net gain of 12 holders — while 58 added to existing stakes and 29 trimmed.

The largest buyer was Millennium Management, adding an estimated $13.3M. The largest seller was Columbia Wanger Asset Management, cutting an estimated $8.86M.

  • 134 institutional investors held Genomic Health, Inc. (GHDX) as of Q3 2017, up from 124 in Q2 2017.
  • Funds reported $1.01B of Genomic Health, Inc. stock for Q3 2017, up 0.08% quarter-over-quarter.
  • 19 funds opened new Genomic Health, Inc. positions in Q3 2017 and 7 closed out, a net change of +12 holders.
  • The largest Genomic Health, Inc. buyer in Q3 2017 was Millennium Management, an estimated $13.3M added.
  • The largest Genomic Health, Inc. seller in Q3 2017 was Columbia Wanger Asset Management, an estimated $8.86M sold.

Based on aggregated 13F filings for Q3 2017.